首页 | 本学科首页   官方微博 | 高级检索  
检索        

三氧化二砷对急性早幼粒细胞白血病初治患者的临床疗效
引用本文:陆进明,何合胜,黄东平,汪兴洪.三氧化二砷对急性早幼粒细胞白血病初治患者的临床疗效[J].实用全科医学,2003,1(3):182-183.
作者姓名:陆进明  何合胜  黄东平  汪兴洪
作者单位:皖南医学院弋矶山医院血液科 241000芜湖市(陆进明,何合胜,黄东平),皖南医学院弋矶山医院血液科 241000芜湖市(汪兴洪)
摘    要:目的 观察三氧化二砷注射液 (As2 O3 )对急性早幼粒细胞白血病 (APL)初治患者的临床疗效。方法 三氧化二砷治疗APL初治患者 2 4例 ,继以DA或HA方案巩固强化治疗。结果  2 4例患者完全缓解率 (CR) 83.3%。 2 0例随访患者均成活 ,最长 5年。中枢神经白血病 (CNSL)发生 9例 (37.5 %)。结论 砷剂用于APL初治患者 ,具有CR率高 ,复发率低 ,不良反应轻 ,且与全反式维甲酸 (ATRT)无交叉耐药性等特点 ,是治疗APL较理想的制剂。

关 键 词:三氧化二砷  白血病  早幼粒细胞  急性  初治
修稿时间:2003年5月26日

Clinical effects of As2O3 in previously untreated patients of acute promyelocytic leukemia
LU Jinming,HE Hesheng,HUANG Dongping,et al..Clinical effects of As2O3 in previously untreated patients of acute promyelocytic leukemia[J].Applied Journal Of General Practice,2003,1(3):182-183.
Authors:LU Jinming  HE Hesheng  HUANG Dongping  
Institution:LU Jinming,HE Hesheng,HUANG Dongping,et al. Yijishan Hospital Affiliated to Wannan Medical College,Anhui 241000
Abstract:Objective To observe the clinical effects of arsenic trioxide (As 2O 3) in acute promyelocytic leukemia(APL) patients. Methods As 2O 3 was given to twenty-four previously untreated APL patients ,and DA or HA regimens were used as maintance treatment. Results Complete remission rate(CR) was 83.3%. The longest survival time among twenty follow-up surrey patients was five years .There were 9 cases with central nervous system leukemia (CNSL) (37.5%). Conclusion The CR rate was high,the relapse was low , the side effect was mild ,and no cross drug-resistance with all-trans retinoic acid(ATRT). As 2O 3 was a new promising differentiation-inducing agent for APL.
Keywords:Arsenic trioxide  Leukemia  Promyelocytic  Acute  Previous treatment
本文献已被 CNKI 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号